Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지
DOI QR코드

DOI QR Code

A Neonate Diagnosed with Wolff-Parkinson-White Syndrome Presenting with Cardiogenic Shock

  • Ha, Ji Eun (Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Lee, Sun Hyang (Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Park, Ga Young (Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Shin, Young-Lim (Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Kim, Sung Shin (Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Jang, Mi-Ae (Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine)
  • Received : 2021.01.13
  • Accepted : 2021.03.29
  • Published : 2021.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

We present the case of a healthy 28-day-old female full-term neonate who was admitted to the neonatal intensive care unit for severe metabolic acidosis, hypoglycemia, and an initial sinus rhythm. The first diagnostic hypothesis was hypovolemic shock, and fluid resuscitation was started immediately. During fluid therapy, cardiovascular collapse occurred with supraventricular tachycardia. The latter was successfully treated with adenosine and beta-blockers. After 8 days, electrocardiography showed ventricular pre-excitation, and Wolff-Parkinson-White syndrome was diagnosed. A novel variant of the MYL2 gene that is related to hypertrophic cardiomyopathy and conduction defect was found after discharge. Cardiogenic shock should be considered, despite being a rare cause of shock in neonates.

Keywords

References

  1. Chambers S, Jnah A, Newberry D. The pathophysiology, diagnosis, and management of Wolff-Parkinson-White syndrome in the neonate. Adv Neonatal Care 2020 Aug 19 [Epub]. https://doi.org/10.1097/ANC.0000000000000785.
  2. Hoeffler CD, Krenek ME, Brand MC. Wolff-Parkinson-White syndrome in a term infant presenting with cardiopulmonary arrest. Adv Neonatal Care 2016;16:44-51. https://doi.org/10.1097/ANC.0000000000000246
  3. Tsao S, Deal BJ. Management of symptomatic Wolff-Parkinson-White syndrome in childhood. Prog Pediatr Cardiol 2013;35:7-15. https://doi.org/10.1016/j.ppedcard.2012.11.002
  4. Dharnidharka VR, Lieh-Lai M, Sarnaik A, Clapp S. A child with cardiogenic shock and supraventricular tachycardia presenting in normal sinus rhythm. Pediatr Emerg Care 1996;12:420-1. https://doi.org/10.1097/00006565-199612000-00008
  5. Gikonyo BM, Dunnigan A, Benson DW Jr. Cardiovascular collapse in infants: association with paroxysmal atrial tachycardia. Pediatrics 1985;76:922-6. https://doi.org/10.1542/peds.76.6.922
  6. Viveiros E, Aveiro AC, Costa E, Nunes JL. Cardiogenic shock in a neonate. BMJ Case Rep 2013;2013:bcr2012008440. https://doi.org/10.1136/bcr-2013-201554
  7. Al-Khatib SM, Pritchett EL. Clinical features of Wolff-ParkinsonWhite syndrome. Am Heart J 1999;138(3 Pt 1):403-13. https://doi.org/10.1016/S0002-8703(99)70140-7
  8. Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation 1993;87:866-73. https://doi.org/10.1161/01.CIR.87.3.866
  9. Richardson C, Silver ES. Management of supraventricular tachycardia in infants. Paediatr Drugs 2017;19:539-51. https://doi.org/10.1007/s40272-017-0254-0
  10. MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins HC, et al. Familial hypertrophic cardiomyopathy with WolffParkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995;96:1216-20. https://doi.org/10.1172/JCI118154
  11. van der Steld LP, Campuzano O, Perez-Serra A, Moura de Barros Zamorano M, Sousa Matos S, Brugada R. Wolff-Parkinson-White syndrome with ventricular hypertrophy in a Brazilian family. Am J Case Rep 2017;18:766-76. https://doi.org/10.12659/AJCR.904613
  12. Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatr 2008;97:1035-9. https://doi.org/10.1111/j.1651-2227.2008.00823.x
  13. Riggs TW, Byrd JA, Weinhouse E. Recurrence risk of supraventricular tachycardia in pediatric patients. Cardiology 1999;91:25-30. https://doi.org/10.1159/000006873
  14. National Center for Biotechnology Information, U.S. National Library of Medicine. MYL2 myosin light chain 2 [homo sapiens (human)] [Internet]. Bethesda: NCBI Gene; 2020 [cited 2021 May 12]. Available from: http://www.ncbi.nlm.nih.gov/gene/4633.
  15. Andersen PS, Havndrup O, Hougs L, Sorensen KM, Jensen M, Larsen LA, et al. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat 2009;30:363-70. https://doi.org/10.1002/humu.20862
  16. Claes GR, van Tienen FH, Lindsey P, Krapels IP, Helderman-van den Enden AT, Hoos MB, et al. Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers. Eur Heart J 2016;37:1815-22. https://doi.org/10.1093/eurheartj/ehv522
  17. Ho CY, Day SM, Colan SD, Russe ll MW, Towbin JA, Sherrid MV, et al. The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet study. JAMA Cardiol 2017;2:419-28. https://doi.org/10.1001/jamacardio.2016.5670